CRISPR Hopes for ALS – GenomeWeb
Next Big Future |
CRISPR Hopes for ALS
GenomeWeb Researchers are testing whether gene editing might be possible treatment avenue for diseases like amyotrophic lateral sclerosis, Gizmodo reports. While most cases of ALS aren’t familial, a small portion is, and about 20 percent of those familial ALS … CRISPR extends lifespan of Lou Gehrigs disease mice by 25%Next Big Future First step toward CRISPR cure of Lou Gehrig’s diseaseEurekAlert (press release) Gene Editing Delays Disease Onset in ALS Model MiceAlzforum ALS News Today all 7 news articles » |
PharmaTimes |
J&J enters CAR–T field with $350M Legend deal
BioPharma Dive Johnson & Johnson has bought itself a foothold in the accelerating CAR–T field, paying $350 million upfront through its subsidiary Janssen Biotech Inc. to gain access to a cancer cell therapy candidate developed by a previously little-known Chinese … Janssen buys into Legend’s CART therapyPharmaTimes Chinese biotech firm Genscript’s shares jump by a third on US$350m Johnson & Johnson unit tie-upSouth China Morning Post |
Futurism |
The FDA Approves a New Gene Therapy Treatment for a Rare Form of Blindness
Futurism The U.S. Food and Drug Administration (FDA) has approved the use of a new form of gene therapy that targets a rare inherited eye disease. The FDA panel had voted to approve the therapy back in October. The treatment, voretigene neparvovec, will now be … Gene therapy could prevent blindnessInnovators Magazine FDA approves Spark’s gene remedy for uncommon blindness pioneered at CHOPKaplan Herald |